Detection of anthracycline-induced cardiotoxicity using perfusion-corrected


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
18 01 2019
Historique:
received: 11 07 2018
accepted: 23 11 2018
entrez: 20 1 2019
pubmed: 20 1 2019
medline: 14 4 2020
Statut: epublish

Résumé

By the time cardiotoxicity-associated cardiac dysfunction is detectable by echocardiography it is often beyond meaningful intervention.

Identifiants

pubmed: 30659226
doi: 10.1038/s41598-018-36721-5
pii: 10.1038/s41598-018-36721-5
pmc: PMC6338786
doi:

Substances chimiques

Anthracyclines 0
Organotechnetium Compounds 0
Radiopharmaceuticals 0
Technetium Tc 99m Sestamibi 971Z4W1S09

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

216

Subventions

Organisme : British Heart Foundation
ID : PG/10/20/28211
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT 203148/Z/16/Z
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/16/43/32141
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RE/08/003
Pays : United Kingdom
Organisme : British Heart Foundation (BHF)
ID : pg/10/20/28211
Pays : International
Organisme : Department of Health
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/15/60/31629
Pays : United Kingdom
Organisme : British Heart Foundation (BHF)
ID : RE/08/003
Pays : International
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Cancer Research UK
Pays : United Kingdom
Organisme : Medical Research Council
Pays : United Kingdom
Organisme : British Heart Foundation (BHF)
ID : PG/15/60/31629
Pays : International

Références

Circulation. 1999 Oct 12;100(15):1653-9
pubmed: 10517738
J Clin Oncol. 2002 Mar 1;20(5):1215-21
pubmed: 11870163
Biochim Biophys Acta. 2002 Oct 9;1588(1):94-101
pubmed: 12379319
Cancer. 2003 Jun 1;97(11):2869-79
pubmed: 12767102
Am J Physiol Heart Circ Physiol. 2007 Jan;292(1):H378-86
pubmed: 16951044
Am J Physiol Heart Circ Physiol. 2007 Apr;292(4):H2009-19
pubmed: 17189352
J Am Coll Cardiol. 2007 Oct 9;50(15):1435-41
pubmed: 17919562
J Clin Oncol. 2008 Jul 1;26(19):3159-65
pubmed: 18591554
Breast Cancer Res Treat. 2009 Sep;117(2):357-64
pubmed: 19082707
Ann Oncol. 2009 May;20(5):816-27
pubmed: 19153118
Free Radic Biol Med. 2009 Jun 15;46(12):1589-97
pubmed: 19303434
Anticancer Drugs. 2010 Jul;21(6):578-90
pubmed: 20375725
JAMA. 2010 Jul 14;304(2):172-9
pubmed: 20628130
J Pharm Sci. 2011 Sep;100(9):3951-8
pubmed: 21590773
Pharmacol Ther. 2012 Jan;133(1):26-39
pubmed: 21839775
J Nucl Med. 1990 Oct;31(10):1646-53
pubmed: 2213187
Circulation. 1990 Nov;82(5):1826-38
pubmed: 2225379
Nat Protoc. 2012 May 31;7(6):1235-46
pubmed: 22653162
Am J Cardiovasc Dis. 2012;2(4):293-300
pubmed: 23173103
J Am Coll Cardiol. 2013 May 14;61(19):2007-17
pubmed: 23501381
Curr Treat Options Cardiovasc Med. 2013 Aug;15(4):410-24
pubmed: 23677704
EJNMMI Res. 2013 Nov 14;3(1):74
pubmed: 24225195
Curr Opin Cardiol. 2014 Jan;29(1):103-12
pubmed: 24284979
J Clin Invest. 2014 Feb;124(2):617-30
pubmed: 24382354
J Nucl Med. 2014 Mar;55(3):488-94
pubmed: 24421288
Circ Heart Fail. 2015 Jan;8(1):98-108
pubmed: 25420486
PLoS One. 2015 Jan 16;10(1):e0117091
pubmed: 25594546
J Natl Cancer Inst. 2015 Feb 23;107(4):null
pubmed: 25713164
JAMA Intern Med. 2015 Jun;175(6):1007-17
pubmed: 25915855
Cardiovasc Drugs Ther. 2017 Feb;31(1):63-75
pubmed: 28185035
Cancer Res. 1986 May;46(5):2295-9
pubmed: 3697976
Int J Nucl Med Biol. 1984;11(3-4):225-34
pubmed: 6335711
J Nucl Med. 1995 Nov;36(11):2075-9
pubmed: 7472602
J Physiol. 1995 Jul 1;486 ( Pt 1):1-13
pubmed: 7562625
J Nucl Med. 1995 Jun;36(6):1069-77
pubmed: 7769430
Anal Biochem. 1993 Oct;214(1):278-83
pubmed: 8250235
Eur J Nucl Med. 1997 Feb;24(2):150-9
pubmed: 9021112

Auteurs

Zaitulhusna M Safee (ZM)

School of Biomedical Engineering and Imaging Sciences, London, UK.

Friedrich Baark (F)

School of Biomedical Engineering and Imaging Sciences, London, UK.

Edward C T Waters (ECT)

School of Biomedical Engineering and Imaging Sciences, London, UK.

Mattia Veronese (M)

Department of Neuroimaging, London, UK.

Victoria R Pell (VR)

School of Biomedical Engineering and Imaging Sciences, London, UK.

James E Clark (JE)

School of Cardiovascular Medicine and Sciences, London, UK.

Filipa Mota (F)

School of Biomedical Engineering and Imaging Sciences, London, UK.

Lefteris Livieratos (L)

School of Biomedical Engineering and Imaging Sciences, London, UK.

Thomas R Eykyn (TR)

School of Biomedical Engineering and Imaging Sciences, London, UK.

Philip J Blower (PJ)

School of Biomedical Engineering and Imaging Sciences, London, UK.

Richard Southworth (R)

School of Biomedical Engineering and Imaging Sciences, London, UK. richard.southworth@kcl.ac.uk.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH